185 related articles for article (PubMed ID: 17724472)
1. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis.
Lin DI; Lessie MD; Gladden AB; Bassing CH; Wagner KU; Diehl JA
Oncogene; 2008 Feb; 27(9):1231-42. PubMed ID: 17724472
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.
Lin DI; Barbash O; Kumar KG; Weber JD; Harper JW; Klein-Szanto AJ; Rustgi A; Fuchs SY; Diehl JA
Mol Cell; 2006 Nov; 24(3):355-66. PubMed ID: 17081987
[TBL] [Abstract][Full Text] [Related]
3. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
4. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
Muraoka RS; Lenferink AE; Law B; Hamilton E; Brantley DM; Roebuck LR; Arteaga CL
Mol Cell Biol; 2002 Apr; 22(7):2204-19. PubMed ID: 11884607
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.
Zhu S; Mott RT; Fry EA; Taneja P; Kulik G; Sui G; Inoue K
Am J Pathol; 2013 Oct; 183(4):1339-1350. PubMed ID: 23938323
[TBL] [Abstract][Full Text] [Related]
8. Leptin regulates cyclin D1 in luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumors.
Zheng Q; Hursting SD; Reizes O
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1607-12. PubMed ID: 22692856
[TBL] [Abstract][Full Text] [Related]
9. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
10. Prolactin promotes mammary pathogenesis independently from cyclin D1.
Asher JM; O'Leary KA; Rugowski DE; Arendt LM; Schuler LA
Am J Pathol; 2012 Jul; 181(1):294-302. PubMed ID: 22658484
[TBL] [Abstract][Full Text] [Related]
11. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.
Casimiro MC; Di Sante G; Crosariol M; Loro E; Dampier W; Ertel A; Yu Z; Saria EA; Papanikolaou A; Li Z; Wang C; Addya S; Lisanti MP; Fortina P; Cardiff RD; Tozeren A; Knudsen ES; Arnold A; Pestell RG
Oncotarget; 2015 Apr; 6(11):8525-38. PubMed ID: 25940700
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
13. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA
Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA; Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
[TBL] [Abstract][Full Text] [Related]
16. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
[TBL] [Abstract][Full Text] [Related]
17. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.
Balasenthil S; Sahin AA; Barnes CJ; Wang RA; Pestell RG; Vadlamudi RK; Kumar R
J Biol Chem; 2004 Jan; 279(2):1422-8. PubMed ID: 14530270
[TBL] [Abstract][Full Text] [Related]
18. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
Michaelson JS; Leder P
Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
[TBL] [Abstract][Full Text] [Related]
19. The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation.
Vaites LP; Lee EK; Lian Z; Barbash O; Roy D; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Mol Cell Biol; 2011 Nov; 31(22):4513-23. PubMed ID: 21911473
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.
Zhang Q; Sakamoto K; Liu C; Triplett AA; Lin WC; Rui H; Wagner KU
Cancer Res; 2011 Dec; 71(24):7513-24. PubMed ID: 22037875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]